Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Instil Bio Inc TIL

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.


NDAQ:TIL - Post by User

Bullboard Posts
Post by manifest30on Nov 15, 2011 10:28pm
432 Views
Post# 19240455

I need... INFO! Thanks

I need... INFO! Thanks

Hey guys i'm new to this play.. I'm mostly in oil stocks, but i'm slowly diversifying into some metals

I currently hold PEM and purchased 2000 shares of this in the last couple days at a .755 average. This stock was hovering around 1.20+ before the markets got really bad. A friend at work told me about these guys.

I will do some DD but i'd like to hear from a knowledgeable investor on what this company has going for it?

I'm what my buddy tells me.. they're been finding decent gold grades and supposedly the infastructure is great( roads close to propety etc) is this true?

pros cons of this play! thanks in advance to anyone that's taken the time to give me the rundown.

some of my holdings are SU, COS, LFD,WZR, PEM, CLL, INT, SDX, ELR, NET, BAC amd recently added HOD.. oil at $99.00 after being at $75 not too long ago.. i figure we're due for a pullback down to low 90's before we rise much over 100..

I realise i hold alot of oil so oil going down wouldn't be great but small moves shouldn't effect the stocks too much.. especially when so many are undervalued. especially COS

I work for Syncrude canada and while production in Q4 will miss targets we're running smooth.. out biggest hydrogen plant 9-4 is down for unscheduled maintanance and won't be back up until the new year so we can't hydrotreater our oil in our upgraders where i work without the hydrogen!... dividend soon though i'm accumulating.

In any case GPD! sell me on this play a little more please :)

Bullboard Posts